chloroxine
AlkaPlorer ID: AK065493
Synonym: None
IUPAC Name: 5,7-dichloroquinolin-8-ol
Structure
SMILES: OC1=C(Cl)C=C(Cl)C2=CC=CN=C12
InChI: InChI=1S/C9H5Cl2NO/c10-6-4-7(11)9(13)8-5(6)2-1-3-12-8/h1-4,13H
InChIKey: WDFKMLRRRCGAKS-UHFFFAOYSA-N
Source
| Species | Genus | Family | Order | Class | Phylum | Kingdom | Domain |
|---|
Properties Information
Molecule Weight: 214.051
TPSA?: 33.120000000000005
MolLogP?: 3.2472000000000003
Number of H-Donors: 1
Number of H-Acceptors: 2
RingCount: 2
Activities Information
| Organism | Target Name | Standard Type | Standard Value | Standard Units | doi |
|---|---|---|---|---|---|
| Acinetobacter baumannii | Acinetobacter baumannii | MIC | 10000.0 | nM | 10.6019/CHEMBL4513141 |
| Candida albicans | Candida albicans | IC50 | 1200.0 | nM | 10.1021/acs.jmedchem.6b01203 |
| Candida albicans | Candida albicans | IC50 | 2700.0 | nM | 10.1021/acs.jmedchem.6b01203 |
| Candida albicans | Candida albicans | MIC | 1250.0 | nM | 10.6019/CHEMBL4513141 |
| Clostridium botulinum | Botulinum neurotoxin type A | IC50 | 11500.0 | nM | 10.1021/jm4012164 |
| Cryptococcus neoformans | Cryptococcus neoformans | MIC | 2500.0 | nM | 10.6019/CHEMBL4513141 |
| Escherichia coli | Beta-galactosidase | EC50 | 31500.0 | nM | None |
| Escherichia coli | Escherichia coli | MIC | 10000.0 | nM | 10.6019/CHEMBL4513141 |
| Giardia intestinalis | Putative fructose-1,6-bisphosphate aldolase | Potency | 3154.8 | nM | None |
| Giardia intestinalis | Putative fructose-1,6-bisphosphate aldolase | Potency | 19905.4 | nM | None |
| Homo sapiens | Acetylcholinesterase | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Adenosine A3 receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Aldehyde dehydrogenase 1A1 | Potency | 7079.5 | nM | None |
| Homo sapiens | Alpha-1a adrenergic receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Alpha-2a adrenergic receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Alpha-synuclein | Potency | 4466.8 | nM | None |
| Homo sapiens | Androgen Receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Arachidonate 12-lipoxygenase | IC50 | 1900.0 | nM | 10.1021/jm2005089 |
| Homo sapiens | Arachidonate 12-lipoxygenase | Potency | 1000.0 | nM | None |
| Homo sapiens | Arachidonate 15-lipoxygenase | IC50 | 2400.0 | nM | 10.1021/jm2005089 |
| Homo sapiens | Arachidonate 15-lipoxygenase, type II | IC50 | 28000.0 | nM | 10.1021/jm2005089 |
| Homo sapiens | Arachidonate 15-lipoxygenase, type II | Potency | 25118.9 | nM | None |
| Homo sapiens | Arachidonate 5-lipoxygenase | IC50 | 3600.0 | nM | 10.1021/jm2005089 |
| Homo sapiens | ATPase family AAA domain-containing protein 5 | Potency | 2310.0 | nM | None |
| Homo sapiens | ATPase family AAA domain-containing protein 5 | Potency | 29081.0 | nM | None |
| Homo sapiens | Cellular tumor antigen p53 | Potency | 3162.3 | nM | None |
| Homo sapiens | Cellular tumor antigen p53 | Potency | 7943.3 | nM | None |
| Homo sapiens | Cellular tumor antigen p53 | Potency | 70794.6 | nM | None |
| Homo sapiens | Cyclooxygenase-1 | AC50 | 300.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Cyclooxygenase-1 | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Cytochrome P450 3A4 | Potency | 15848.9 | nM | None |
| Homo sapiens | Delta opioid receptor | EC50 | 32000.0 | nM | None |
| Homo sapiens | Delta opioid receptor | IC50 | 32000.0 | nM | None |
| Homo sapiens | DNA polymerase iota | Potency | 89125.1 | nM | None |
| Homo sapiens | Dopamine D1 receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Dopamine D3 receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Dopamine transporter | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Estrogen receptor alpha | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Geminin | Potency | 3662.6 | nM | None |
| Homo sapiens | Geminin | Potency | 3758.6 | nM | None |
| Homo sapiens | Geminin | Potency | 6683.8 | nM | None |
| Homo sapiens | Geminin | Potency | 20596.2 | nM | None |
| Homo sapiens | Glucagon-like peptide 1 receptor | Potency | 2238.7 | nM | None |
| Homo sapiens | Guanine nucleotide-binding protein G(s), subunit alpha | Potency | 11220.2 | nM | None |
| Homo sapiens | Heat shock protein HSP90 | IC50 | 50000.0 | nM | None |
| Homo sapiens | Heat shock protein HSP 90-alpha | AC50 | 1045.0 | nM | None |
| Homo sapiens | HEK293 | CC50 | 10000.0 | nM | 10.6019/CHEMBL4513141 |
| Homo sapiens | HepG2 | Potency | 1258.9 | nM | None |
| Homo sapiens | HERG | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Histamine H3 receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Histone deacetylase 6 | Inhibition | 6.37 | % | 10.6019/CHEMBL4808148 |
| Homo sapiens | Histone deacetylase 6 | Inhibition | 17.76 | % | 10.6019/CHEMBL4808148 |
| Homo sapiens | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | Potency | 39810.7 | nM | None |
| Homo sapiens | Huntingtin | Potency | 2818.4 | nM | None |
| Homo sapiens | Huntingtin | Potency | 8912.5 | nM | None |
| Homo sapiens | HUVEC | Activity | 95.0 | % | 10.1016/j.bmc.2023.117289 |
| Homo sapiens | Isocitrate dehydrogenase [NADP] cytoplasmic | Potency | 20596.2 | nM | None |
| Homo sapiens | Kappa opioid receptor | IC50 | 4560.0 | nM | None |
| Homo sapiens | Kappa opioid receptor | IC50 | 32000.0 | nM | None |
| Homo sapiens | Liver microsome | Drug metabolism | 0.112 | uM/min.mg | 10.1021/jm4012164 |
| Homo sapiens | Liver microsome | T1/2 | 0.815 | hr | 10.1021/jm4012164 |
| Homo sapiens | LNCaP | CC50 | 2500.0 | nM | 10.1021/jm301632e |
| Homo sapiens | Lysine-specific demethylase 4A | Potency | 28183.8 | nM | None |
| Homo sapiens | Lysine-specific demethylase 4D-like | Potency | 14125.4 | nM | None |
| Homo sapiens | Lysine-specific demethylase 4D-like | Potency | 35481.3 | nM | None |
| Homo sapiens | Matrix metalloproteinase 13 | IC50 | 19600.0 | nM | 10.1016/j.bmc.2023.117289 |
| Homo sapiens | Matrix metalloproteinase 14 | IC50 | 25600.0 | nM | 10.1016/j.bmc.2023.117289 |
| Homo sapiens | Matrix metalloproteinase 14 | Inhibition | nan | % | 10.1016/j.bmc.2023.117289 |
| Homo sapiens | Matrix metalloproteinase 14 | Kd | 2400.0 | nM | 10.1016/j.bmc.2023.117289 |
| Homo sapiens | Matrix metalloproteinase-2 | Inhibition | nan | % | 10.1016/j.bmc.2023.117289 |
| Homo sapiens | Matrix metalloproteinase 7 | Inhibition | nan | % | 10.1016/j.bmc.2023.117289 |
| Homo sapiens | Matrix metalloproteinase 9 | IC50 | 15900.0 | nM | 10.1016/j.bmc.2023.117289 |
| Homo sapiens | Menin/Histone-lysine N-methyltransferase MLL | Potency | 28183.8 | nM | None |
| Homo sapiens | microRNA 21 | Potency | 23280.9 | nM | None |
| Homo sapiens | Microtubule-associated protein tau | Potency | 12589.3 | nM | None |
| Homo sapiens | Microtubule-associated protein tau | Potency | 31622.8 | nM | None |
| Homo sapiens | Monoamine oxidase A | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Mothers against decapentaplegic homolog 3 | Potency | 3548.1 | nM | None |
| Homo sapiens | MT4 | CC50 | nan | None | 10.1021/jm301632e |
| Homo sapiens | Mu opioid receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Mu opioid receptor | EC50 | 32000.0 | nM | None |
| Homo sapiens | Muscarinic acetylcholine receptor M1 | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Muscarinic acetylcholine receptor M2 | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Norepinephrine transporter | AC50 | 5191.5 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Phosphodiesterase 3A | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Phosphodiesterase 4A | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Plasma | Stability | 100.0 | % | 10.1021/jm4012164 |
| Homo sapiens | Plasma | T1/2 | 18.6 | hr | 10.1021/jm4012164 |
| Homo sapiens | Pregnane X receptor | Activity | nan | None | 10.1124/dmd.110.035105 |
| Homo sapiens | Pregnane X receptor | EC50 | 39800.0 | nM | 10.1124/dmd.110.035105 |
| Homo sapiens | Pregnane X receptor | Efficacy | 107.9 | % | 10.1124/dmd.110.035105 |
| Homo sapiens | Prelamin-A/C | Potency | 3981.1 | nM | None |
| Homo sapiens | Prelamin-A/C | Potency | 6309.6 | nM | None |
| Homo sapiens | Progesterone receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Runt-related transcription factor 1/Core-binding factor subunit beta | Potency | 31622.8 | nM | None |
| Homo sapiens | Serotonin 1a (5-HT1a) receptor | AC50 | 17165.2 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Serotonin 2b (5-HT2b) receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Serotonin transporter | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Solute carrier organic anion transporter family member 1B1 | Inhibition | 43.47 | % | 10.1124/mol.112.084152 |
| Homo sapiens | Solute carrier organic anion transporter family member 1B3 | Inhibition | 62.22 | % | 10.1124/mol.112.084152 |
| Homo sapiens | Survival motor neuron protein | Potency | 12589.3 | nM | None |
| Homo sapiens | Survival motor neuron protein | Potency | 35481.3 | nM | None |
| Homo sapiens | Thrombin | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Thromboxane A2 receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Tyrosyl-DNA phosphodiesterase 1 | Potency | 446.7 | nM | None |
| Homo sapiens | Tyrosyl-DNA phosphodiesterase 1 | Potency | 2592.9 | nM | None |
| Homo sapiens | Tyrosyl-DNA phosphodiesterase 1 | Potency | 2909.3 | nM | None |
| Homo sapiens | Tyrosyl-DNA phosphodiesterase 1 | Potency | 7079.5 | nM | None |
| Homo sapiens | Tyrosyl-DNA phosphodiesterase 1 | Potency | 8199.5 | nM | None |
| Homo sapiens | Tyrosyl-DNA phosphodiesterase 1 | Potency | 18356.4 | nM | None |
| Homo sapiens | Vascular endothelial growth factor receptor 2 | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Vitamin D receptor | Potency | 44668.4 | nM | None |
| Human immunodeficiency virus | Human immunodeficiency virus | EC50 | nan | None | 10.1021/jm301632e |
| Human immunodeficiency virus 1 | Aberrant vpr protein | Potency | 4466.8 | nM | None |
| Human immunodeficiency virus 1 | Human immunodeficiency virus type 1 integrase | IC50 | 20000.0 | nM | 10.1021/jm301632e |
| Klebsiella pneumoniae | Klebsiella pneumoniae | MIC | 10000.0 | nM | 10.6019/CHEMBL4513141 |
| Mus musculus | Lanosterol 14-alpha demethylase | Inhibition | nan | % | 10.1021/acs.jmedchem.5b01696 |
| Mus musculus | Matrix metalloproteinase-2 | Inhibition | nan | % | 10.1016/j.bmc.2023.117289 |
| Mus musculus | Nuclear receptor ROR-gamma | Potency | 79.4 | nM | None |
| Mus musculus | Nuclear receptor ROR-gamma | Potency | 281.8 | nM | None |
| Mus musculus | Nuclear receptor ROR-gamma | Potency | 2238721.1 | nM | None |
| Photinus pyralis | Luciferin 4-monooxygenase | Potency | 13459.1 | nM | None |
| Plasmodium falciparum | Plasmodium falciparum | Potency | 4256.2 | nM | None |
| Plasmodium falciparum | Plasmodium falciparum | Potency | 6573.3 | nM | None |
| Plasmodium falciparum | Plasmodium falciparum | Potency | 8492.1 | nM | None |
| Plasmodium falciparum 3D7 | HSP90 | AC50 | 511.0 | nM | None |
| Pseudomonas aeruginosa | Pseudomonas aeruginosa | MIC | 10000.0 | nM | 10.6019/CHEMBL4513141 |
| Rattus norvegicus | Liver microsome | Drug metabolism | 0.1 | uM/min.mg | 10.1021/jm4012164 |
| Rattus norvegicus | Liver microsome | T1/2 | 0.9167 | hr | 10.1021/jm4012164 |
| Rattus norvegicus | Nuclear receptor subfamily 1 group I member 2 | Activity | nan | None | 10.1124/dmd.110.035105 |
| Rattus norvegicus | Peripheral myelin protein 22 | Potency | 3612.5 | nM | None |
| Rattus norvegicus | Peripheral myelin protein 22 | Potency | 28162.5 | nM | None |
| Rattus norvegicus | Plasma | Stability | 100.0 | % | 10.1021/jm4012164 |
| Rattus norvegicus | Plasma | T1/2 | 67.7 | hr | 10.1021/jm4012164 |
| Rattus norvegicus | Thioredoxin reductase 1, cytoplasmic | Potency | 56234.1 | nM | None |
| Saccharomyces cerevisiae | Saccharomyces cerevisiae | Potency | 19952.6 | nM | None |
| Saccharomyces cerevisiae S288c | Ammonium transporter MEP2 | EC50 | 36100000.0 | nM | None |
| Saccharomyces cerevisiae S288c | Citrate synthase, peroxisomal | EC50 | 19750000.0 | nM | None |
| Schistosoma mansoni | Thioredoxin glutathione reductase | Potency | 15848.9 | nM | None |
| Severe acute respiratory syndrome coronavirus 2 | Replicase polyprotein 1ab | IC50 | 7240.0 | nM | 10.1021/acs.jmedchem.2c00303 |
| Severe acute respiratory syndrome coronavirus 2 | Replicase polyprotein 1ab | Inhibition | 5.21 | % | 10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 | Replicase polyprotein 1ab | Inhibition | 21.65 | % | 10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 | Replicase polyprotein 1ab | Kd | 4600.0 | nM | 10.1021/acs.jmedchem.2c00303 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | IC50 | 19952.62 | nM | 10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | IC50 | 20000.0 | nM | 10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Inhibition | -0.15 | % | 10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Inhibition | 0.25 | % | 10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Inhibition | 0.62 | % | 10.21203/rs.3.rs-23951/v1 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Inhibition index | 0.2113 | None | 10.1101/2020.04.03.023846 |
| Staphylococcus aureus | Staphylococcus aureus | MIC | 10000.0 | nM | 10.6019/CHEMBL4513141 |
| Streptococcus | Streptococcus | EC50 | 3306.0 | nM | None |
| Streptococcus pyogenes serotype M1 | Streptokinase A | EC50 | 148.0 | nM | None |
| Streptococcus sp. 'group A' | Streptococcus sp. 'group A' | EC50 | 258.0 | nM | None |
| None | ADMET | Activity | nan | None | 10.1021/acs.jmedchem.5b01696 |
| None | NON-PROTEIN TARGET | Potency | 14950.2 | nM | None |
| None | NON-PROTEIN TARGET | Potency | 18821.2 | nM | None |
| None | NON-PROTEIN TARGET | Potency | 21117.7 | nM | None |
| None | No relevant target | Solubility | 532.0 | nM | 10.1021/jm4012164 |
| None | No relevant target | Solubility | 326000.0 | nM | 10.1021/jm4012164 |
| None | Phospholipidosis | Phospholipidosis | nan | None | 10.1080/15376510701857262 |
| None | Unchecked | AbsAC35_uM | 5.58 | uM | None |
| None | Unchecked | Ac50 | 39.81 | uM | None |
| None | Unchecked | AC50 | 39810.7 | nM | None |
| None | Unchecked | EC50 | 12810.0 | nM | None |
| None | Unchecked | IC50 | 39.34 | nM | None |
| None | Unchecked | IC50 | 43.81 | nM | None |
| None | Unchecked | IC50 | 47.46 | nM | None |
| None | Unchecked | IC50 | 49.33 | nM | None |
| None | Unchecked | IC50 | 62.74 | nM | None |
| None | Unchecked | IC50 | 408.61 | nM | None |
| None | Unchecked | IC50 | 495.2 | nM | None |
| None | Unchecked | IC50 | 779.0 | nM | None |
| None | Unchecked | IC50 | 2000.1 | nM | None |
| None | Unchecked | IC50 | 4300.0 | nM | 10.1021/jm301632e |
| None | Unchecked | IC50 | 10000.0 | nM | None |
| None | Unchecked | IC50 | 10500.0 | nM | None |
| None | Unchecked | IC50 | 17880.0 | nM | None |
| None | Unchecked | IC50 | 20000.0 | nM | None |
| None | Unchecked | IC50 | 27930.0 | nM | None |
| None | Unchecked | Inhibition | 20.0 | % | 10.1016/j.ejmech.2021.113975 |
| None | Unchecked | Inhibition | 23.0 | % | 10.1016/j.ejmech.2021.113975 |
| None | Unchecked | Inhibition | 34.0 | % | 10.1016/j.ejmech.2021.113975 |
| None | Unchecked | Inhibition | 50.0 | % | 10.1021/jm301632e |
| None | Unchecked | Inhibition | 90.0 | % | 10.1016/j.ejmech.2021.113975 |
| None | Unchecked | Inhibition | 95.0 | % | 10.1016/j.ejmech.2021.113975 |
| None | Unchecked | Inhibition | 97.0 | % | 10.1016/j.ejmech.2021.113975 |
| None | Unchecked | Inhibition | 98.0 | % | 10.1016/j.ejmech.2021.113975 |
| None | Unchecked | Inhibition | 99.0 | % | 10.1016/j.ejmech.2021.113975 |
| None | Unchecked | Max_Activity | 26.0 | uM | None |
| None | Unchecked | Potency | 1778.3 | nM | None |
| None | Unchecked | Potency | 6309.6 | nM | None |
| None | Unchecked | Potency | 7079.5 | nM | None |
| None | Unchecked | Potency | 7943.3 | nM | None |
| None | Unchecked | Potency | 10000.0 | nM | None |
| None | Unchecked | Potency | 12589.3 | nM | None |
| None | Unchecked | Potency | 18356.4 | nM | None |
| None | Unchecked | Potency | 19952.6 | nM | None |
| None | Unchecked | Potency | 20596.2 | nM | None |
| None | Unchecked | Potency | 22387.2 | nM | None |
| None | Unchecked | Potency | 25118.9 | nM | None |
| None | Unchecked | Potency | 35481.3 | nM | None |
| None | Unchecked | Potency | 40533.4 | nM | None |
